- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01838980
Evaluation of the Motus GI CleanUp System During Screening Colonoscopy
December 26, 2016 updated by: Motus GI Medical Technologies Ltd
Evaluation of the Motus GI CleanUp System During Screening
Motus GI is developing a single-use device that attaches to a standard colonoscope, thereby integrating colon cleansing, screening and treatment into one procedure.
The device creates turbulence within the colon using water jets.
The colon's fecal fluids are evacuated by the system.
Study Overview
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 69 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subjects in the age range of 50-69 years
- Subjects who are considered for routine screening colonoscopy
- Subjects with BMI within the range of 18.5-30
- Subject is willing to sign informed consent form
Exclusion Criteria:
- History of GI diseases or history of Colorectal cancer (personal or family)
- Previous major abdominal surgeries
- Medical status ASA grater or equal to 3
- Acute GI symptoms, such as bleeding, unexplained weight loss, inflammatory bowel disease (IBD).
- Patients taking anticoagulants (e.g., Coumadin, Heparin, Clopidrogrel)
- Life-threatening condition
- Subjects who are unable or unwilling to cooperate with study procedures
- Severe Diverticula
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Colonoscopy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean of All Subjects Colon Segments BBPS>=2
Time Frame: Following the colonoscopic procedure- Up to 24 hours.
|
Human colon has 3 segments and each segment can be scored 0 (unprepared colon) - 3 (clean colon). Summing all colon segments BBPS score of all participants dividing in the number of segments is expected to be >=2. |
Following the colonoscopic procedure- Up to 24 hours.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2013
Primary Completion (Actual)
February 1, 2014
Study Completion (Actual)
February 1, 2014
Study Registration Dates
First Submitted
April 21, 2013
First Submitted That Met QC Criteria
April 23, 2013
First Posted (Estimate)
April 24, 2013
Study Record Updates
Last Update Posted (Actual)
February 14, 2017
Last Update Submitted That Met QC Criteria
December 26, 2016
Last Verified
April 1, 2014
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CP-MCU-IL-0412
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
De-identified individual participant data for all primary and secondary outcome measures may be made available in the future
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on CRC
-
Motus GI Medical Technologies LtdTerminated
-
Chinese University of Hong KongWithdrawn
-
Motus GI Medical Technologies LtdCompleted
-
Motus GI Medical Technologies LtdCompleted
-
Shanghai Henlius BiotechNot yet recruiting
-
Motus GI Medical Technologies LtdCompleted
-
The Netherlands Cancer InstituteErasmus Medical Center; Amsterdam University Medical Centres (AUMC)Active, not recruitingCRC | Advanced NeoplasiaNetherlands
-
Jacobio Pharmaceuticals Co., Ltd.RecruitingNSCLC | Solid Tumor | CRCChina
-
jianming xuKAEDIRecruiting
-
SparX Biotech(Jiangsu) Co., Ltd.RecruitingSolid Tumor | CRC | HNSCC | RCCUnited States
Clinical Trials on Motus GI Clean-Up Device
-
Nuovo Regina Margherita HospitalCompleted
-
Geok Lin KhorFonterra Research CentreUnknownCognitive Function | Mood BehaviourMalaysia
-
Fondazione Poliambulanza Istituto OspedalieroRecruitingAdenoma | Polyp of Colon | Colonic AdenomaItaly
-
Shenzhen Hospital of Southern Medical University964 hospital of joint Logistics Support Force; The Chinese people's liberation...Not yet recruiting
-
Central Hospital, Nancy, FranceDr Coraline HINGRAY; Pr Raymund SCHWAN; Dr Vincent LAPREVOTE; Dr Jean Pierre VIGNAL and other collaboratorsUnknownPsychogenic Non Epileptic SeizureFrance
-
Fondazione Poliambulanza Istituto OspedalieroRecruitingRectal Neoplasms | Colonic Neoplasms | Rectal Adenocarcinoma | Colonic Adenocarcinoma | Polyps of ColonItaly
-
Institut Claudius RegaudCompleted
-
University Hospital, ToulouseCompleted
-
Cliniche Humanitas GavazzeniCompletedCardiac Pacemaker, Artificial | Implantable Cardioverter-DefibrillatorItaly